FDA Names Tracy Beth Høeg as Acting CDER Director After Richard Pazdur Announces Retirement 
Eli Lilly Becomes First Pharma Giant to Hit $1 Trillion Amid Soaring Weight-Loss Drug Demand 
U.S. Experts to Reassess Newborn Hepatitis B Vaccination Guidelines Amid Growing Debate 
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment 
Obamacare Premiums Set to Double in 2026 as Subsidy Expiration Looms Amid U.S. Shutdown 
Pfizer Boosts Bid for Metsera Amid Intensifying Rivalry with Novo Nordisk in Obesity Drug Market 
Merck Nears Acquisition of Cidara Therapeutics at Significant Premium 
Pfizer Secures $10 Billion Deal for Obesity Drug Developer Metsera, Outbids Novo Nordisk 
Trump Signs Executive Order to Boost AI Research in Childhood Cancer 
Trump Hints at Major Autism Announcement, Raises Questions on Tylenol Link 
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage 
Canada Loses Measles-Free Status After Nearly 30 Years Amid Declining Vaccination Rates 
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment 
One of the biggest challenges that doctors and scientists are faced with today is developing a cure for the deadly virus known as HIV or AIDS. Having become prevalent for decades, responsible for taking millions of lives, everyone is on the search for a cure, and patients are willing to risk their lives to make it happen.
As the HIV/AIDS epidemic rages on, there has been some progress made towards developing a cure to the deadly disease over recent years. A new study on the disease, titled “HIV Cure Research,” revealed that a portion of people who are HIV-positive are willing to risk their lives in the clinical trials. To them, they are willing to risk near-certain death if it means helping in developing a cure. According to a patient that was interviewed, “I’m not going to live forever… It is about the next man, the next woman, and you have to have the mindset to care about people, which I do.”
Another patient that was also interviewed explained that they are willing to go this far for the community living with the disease. They expressed their hope at how much of a game-changer it would be to see a cure made.
On the other hand, the authors of the study explained that if HIV-positive patients are allowed to volunteer for the experiments, they said that there should be ethical safeguards placed. This is to ensure that patients have a say in their involvement in research that has the possibility to be fatal for them.
Everyone is putting a united front in battling the disease to put a stop to the epidemic once and for all. Scientists from the University of Nebraska Medical Center and Temple University were able to come up with a kind of therapy that cured the virus of living animals. This was the biggest breakthrough towards the journey for the cure to HIV/AIDS, and the future is bright for the cure for humans.
According to Dr. Howard Gendelman of the University of Nebraska, they are moving closer to making human trials for the type of therapy that could potentially cure HIV/AIDS. Referred to as LASER-ART - which is a slow-effect release antiretroviral therapy, with a few more tests and experiments, it could be ready for human trials within the upcoming year or two.
